Navigation Links
Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
Date:12/18/2012

New York, New York (PRWEB) December 18, 2012

The runaway biotech bestseller, WIRED, was not only a New York Times and USA Today bestseller, but the bestselling Kindle novel of 2011 in two major categories—science fiction and technothrillers—an unprecedented achievement.

Now, as the WIRED sequel, AMPED, climbs the charts to glowing reviews, the eBook version of WIRED has regained the top spot on Amazon's technothriller list, and is being offered on Amazon for only $5.95. The author of these books, Douglas E. Richards, has been frequently compared to the late Michael Crichton for his ability to weave action, suspense, and well-researched science into riveting page-turners.

Richards has a master's degree in genetic engineering and was a biotechnology executive for many years. "When I wrote WIRED," he explains, "I asked myself the question: what if it were possible to boost human IQ to immeasurable levels for short periods of time? What capabilities might this confer? What changes to attitude and personality? Would this bring out our better angels or unleash our darker sides, causing us to grow ever more drunk with power?"

Both WIRED and AMPED answer these questions in a way that bestselling author Boyd Morrison calls, "action-packed, breathtaking, and mind-blowing."

According to SFRevu founder, Ernest Lilley, "WIRED has a twisty plot, big ideas, and nonstop action and intrigue. It'll have you guessing until the very end."

To learn more about Richards and his work, visit his website at http://www.douglaserichards.com or Friend him on Facebook at Douglas E. Richards Author.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10225385.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Bar Harbor BioTechnology to Offer Direct Sales Starting in 2013; Development of StellARrays™ for C.elegans and Zebrafish Underway
2. Milo Biotechnology Announces FDA Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
3. Global Agricultural Biotechnology Industry
4. Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
5. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
6. David Lichtenstein: Biotechnology is Rich Area for Investment
7. Germany Prioritizes Medical Biotechnology with New Initiatives
8. Biomass characterization technology research highlighted in Industrial Biotechnology journal
9. Bolder BioTechnology Announces Publication of Data Demonstrating Utility of the Companys Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury
10. Global Marine Biotechnology Industry
11. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Mar 23, 2017 Research and Markets ... Markets" report to their offering. ... The Global Market for ... in 2016 at a CAGR of 8.9%, ... non-energetic bioproducts into seven major product segments: bio-derived chemicals, biofuels, ...
(Date:3/23/2017)... , March 23, 2017  SeraCare Life ... global in vitro diagnostics manufacturers and clinical ... industry,s first multiplexed Inherited Cancer reference ... by next-generation sequencing (NGS). The Seraseq™ Inherited ... with input from industry experts to validate ...
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
Breaking Biology Technology:
(Date:3/7/2017)... England , March 7, 2017 Brandwatch , ... chosen by The Prince,s Trust to uncover insights to ... across The Trust. The UK,s leading youth charity will ... social campaign results and get a better understanding of the topics ... ...
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... 2017   Acuant , a leading provider of ... enhancements to new and core technologies building upon the ... mobile and desktop Acuant FRM TM facial recognition ... real time manual review of identity documents by accredited ... fastest and most accurate capture software to streamline workflows ...
Breaking Biology News(10 mins):